Back to Journals » Lung Cancer: Targets and Therapy » Volume 10

Lung Cancer: Targets and Therapy


Archive: Volume 10, 2019

Outcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer

Mix M, Tanny S, Nsouli T, Alden R, Chaudhari R, Kincaid R, Rosenbaum PF, Bogart JA, Aridgides P

Lung Cancer: Targets and Therapy 2019, 10:151-159

Published Date: 20 December 2019

Approaches to Tumor Classification in Pulmonary Sarcomatoid Carcinoma

Baldovini C, Rossi G, Ciarrocchi A

Lung Cancer: Targets and Therapy 2019, 10:131-149

Published Date: 5 December 2019

Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies

Gadgeel S, Shaw AT, Barlesi F, Crino L, Yang JCH, Dingemans AM, Kim DW, de Marinis F, Schulz M, Liu S, Gupta R, Smoljanovic V, Ou SHI

Lung Cancer: Targets and Therapy 2019, 10:125-130

Published Date: 13 November 2019

Landscape on CT screening for lung cancer in Asia

Triphuridet N, Henschke C

Lung Cancer: Targets and Therapy 2019, 10:107-124

Published Date: 30 September 2019

A retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors

Nagasaka M, Abdallah N, Crosby M, Thummala N, Patel D, Wozniak AJ, Gadgeel S, Abrams J, Sukari A

Lung Cancer: Targets and Therapy 2019, 10:95-105

Published Date: 12 September 2019

TKI-resistant ALK-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations

Ouseph MM, Taber A, Khurshid H, Madison R, Aswad BI, Resnick MB, Yakirevich E, Ali SM, Patel NR

Lung Cancer: Targets and Therapy 2019, 10:81-86

Published Date: 15 August 2019

Impact of smoking on frequency and spectrum of K-RAS and EGFR mutations in treatment naive Indonesian lung cancer patients

Masykura N, Zaini J, Syahruddin E, Andarini SL, Hudoyo A, Yasril R, Ridwanuloh A, Hidajat H, Nurwidya F, Utomo A

Lung Cancer: Targets and Therapy 2019, 10:57-66

Published Date: 17 June 2019

Pain management in patients with malignant mesothelioma: challenges and solutions

Saunders J, Ashton M, Hall C, Laird B, MacLeod N

Lung Cancer: Targets and Therapy 2019, 10:37-46

Published Date: 2 April 2019

Targeting RET-rearranged non-small-cell lung cancer: future prospects

Bronte G, Ulivi P, Verlicchi A, Cravero P, Delmonte A, Crinò L

Lung Cancer: Targets and Therapy 2019, 10:27-36

Published Date: 20 March 2019

Systematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer

Barrows SM, Wright K, Copley-Merriman C, Kaye JA, Chioda M, Wiltshire R, Torgersen KM, Masters ET

Lung Cancer: Targets and Therapy 2019, 10:11-20

Published Date: 8 February 2019

Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis

Kate S, Chougule A, Joshi A, Noronha V, Patil V, Dusane R, Solanki L, Tiwrekar P, Trivedi V, Prabhash K

Lung Cancer: Targets and Therapy 2019, 10:1-10

Published Date: 29 January 2019